IMARC Group’s report titled “Enteric Softgel Capsules Market Report by Type (Gelatin Capsules, Non-Gelatin Softgel Capsules), Application (Health Supplements, Pharmaceuticals), Distribution Channel (Supermarkets and Hypermarkets, Pharmacy and Drug Stores, Online Stores), and Region 2025-2033” The global enteric softgel capsules market size reached USD 2.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.6% during 2025-2033.

Factors Affecting the Growth of the Enteric Softgel Capsules Industry:

  • Rising Demand for Supplements:

The demand for enteric softgel capsules is rising. More people are using dietary supplements to stay healthy. These capsules shield ingredients like probiotics and omega-3s from stomach acid. This helps them work better by releasing in the intestines. They are also easier to swallow than tablets, which makes them popular. As people focus on boosting their immunity and health, the need for these capsules grows. By 2024, manufacturers plan to create more specialized capsules to meet these demands.

  • Better Capsule Technology:

New technology is enhancing enteric softgel capsules. Stronger coatings protect ingredients better. This means they dissolve in the intestines, where they work best. Faster and cheaper manufacturing helps companies create capsules for specific health needs, like improved digestion or increased energy. These advancements boost both quality and appeal. By 2024, even better capsule options will emerge, aligning with health trends.

  • Quality and Safety Matter:

Consumers want safe, high-quality supplements. Companies follow strict rules to test their products and meet health standards. Many people prefer certified products for extra trust. Transparency matters too; consumers want to know the source of ingredients. By 2024, companies will invest more in testing and certifications to stay competitive and meet customer needs.

Grab a sample PDF of this report: https://www.imarcgroup.com/enteric-softgel-capsules-market/requestsample

Leading Companies Operating in the Global Enteric Softgel Capsules Industry:

  • Aenova Group GmbH
  • BASF SE
  • Catalent, Inc.
  • Colorcon Inc.
  • Fuji Capsule Co. Ltd.
  • Lonza Group AG
  • Now Health Group, Inc.
  • ProCaps Group
  • Super Spectrim
  • Thermo Fisher Scientific, Inc.

Enteric Softgel Capsules Market Report Segmentation:

Breakup by Type:

  • Gelatin Capsules
  • Non-Gelatin Softgel Capsules

Breakup by Application:

  • Health Supplements
  • Pharmaceuticals

Breakup by Distribution Channel:

  • Supermarkets and Hypermarkets
  • Pharmacy and Drug Stores
  • Online Stores

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Enteric Softgel Capsules Market Trends:

The market for enteric softgel capsules is changing to meet consumer demands. Personalized supplements for specific health goals, like digestion or immune support, are becoming popular. Plant-based and vegan capsules are also on the rise as people choose eco-friendly options. Improved technology is making capsules more effective, and sustainability is driving the use of recyclable or biodegradable packaging. These trends will help the market grow, with companies adapting to meet the needs of health-focused and eco-conscious consumers.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145